menu
    • menu
    [{"orgOrder":0,"company":"Pharmaceutical Research Unit, Jordan","sponsor":"Abdi Ibrahim","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"JORDAN","productType":"Antibiotic","year":"2014","type":"Inapplicable","leadProduct":"Dirithromycin","moa":"Bacterial 70S ribosome","graph1":"Undisclosed","graph2":"Phase I","graph3":"Pharmaceutical Research Unit, Jordan","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Tablet, Enteric Coated","sponsorNew":"Pharmaceutical Research Unit, Jordan \/ Abdi Ibrahim","highestDevelopmentStatusID":"6","companyTruncated":"Pharmaceutical Research Unit, Jordan \/ Abdi Ibrahim"},{"orgOrder":0,"company":"Pharmaceutical Research Unit, Jordan","sponsor":"Abdi Ibrahim","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"JORDAN","productType":"Antibiotic","year":"2014","type":"Inapplicable","leadProduct":"Dirithromycin","moa":"Bacterial 70S ribosome","graph1":"Undisclosed","graph2":"Phase I","graph3":"Pharmaceutical Research Unit, Jordan","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Tablet, Enteric Coated","sponsorNew":"Pharmaceutical Research Unit, Jordan \/ Abdi Ibrahim","highestDevelopmentStatusID":"6","companyTruncated":"Pharmaceutical Research Unit, Jordan \/ Abdi Ibrahim"},{"orgOrder":0,"company":"Pharmaceutical Research Unit, Jordan","sponsor":"Abdi Ibrahim","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"JORDAN","productType":"Antibiotic","year":"2014","type":"Inapplicable","leadProduct":"Dirithromycin","moa":"Bacterial 70S ribosome","graph1":"Undisclosed","graph2":"Phase I","graph3":"Pharmaceutical Research Unit, Jordan","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Tablet, Enteric Coated","sponsorNew":"Pharmaceutical Research Unit, Jordan \/ Abdi Ibrahim","highestDevelopmentStatusID":"6","companyTruncated":"Pharmaceutical Research Unit, Jordan \/ Abdi Ibrahim"},{"orgOrder":0,"company":"Pharmaceutical Research Unit, Jordan","sponsor":"Abdi Ibrahim","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"JORDAN","productType":"Antibiotic","year":"2014","type":"Inapplicable","leadProduct":"Dirithromycin","moa":"Bacterial 70S ribosome","graph1":"Undisclosed","graph2":"Phase I","graph3":"Pharmaceutical Research Unit, Jordan","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Tablet, Enteric Coated","sponsorNew":"Pharmaceutical Research Unit, Jordan \/ Abdi Ibrahim","highestDevelopmentStatusID":"6","companyTruncated":"Pharmaceutical Research Unit, Jordan \/ Abdi Ibrahim"}]

    Find Clinical Drug Pipeline Developments & Deals for Dynabac

    Menu

    Dynabac

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Pharmaceutical Research Unit, Jordan

                            Country arrow
                            Aquaexpo
                            Not Confirmed

                            Pharmaceutical Research Unit, Jordan

                            Country arrow
                            Aquaexpo
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Dirithromycin

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase I

                            Sponsor : Abdi Ibrahim

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Semi-replicate Crossover Bioequivalence Study of Dirithromycin of (Abdi İbrahim İlaç San. Ve Tic. A. ...

                            Details : Dirithromycin is a Antibiotic drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Antibiotic

                            Upfront Cash : Inapplicable

                            September 11, 2014

                            Lead Product(s) : Dirithromycin

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase I

                            Sponsor : Abdi Ibrahim

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Pharmaceutical Research Unit, Jordan

                            Country arrow
                            Aquaexpo
                            Not Confirmed

                            Pharmaceutical Research Unit, Jordan

                            Country arrow
                            Aquaexpo
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Dirithromycin

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase I

                            Sponsor : Abdi Ibrahim

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Semi-replicate Crossover Bioequivalence Study of Dirithromycin in Healthy Subjects Under Fed Conditions

                            Details : Dirithromycin is a Antibiotic drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Antibiotic

                            Upfront Cash : Inapplicable

                            September 11, 2014

                            Lead Product(s) : Dirithromycin

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase I

                            Sponsor : Abdi Ibrahim

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Pharmaceutical Research Unit, Jordan

                            Country arrow
                            Aquaexpo
                            Not Confirmed

                            Pharmaceutical Research Unit, Jordan

                            Country arrow
                            Aquaexpo
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Dirithromycin

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase I

                            Sponsor : Abdi Ibrahim

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Bioequivalence Pilot Study of Dirithromycin of (Abdi İbrahim İlaç San.Ve.Tic.A.Ş,Turkey) in Health...

                            Details : Dirithromycin is a Antibiotic drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Antibiotic

                            Upfront Cash : Inapplicable

                            July 10, 2014

                            Lead Product(s) : Dirithromycin

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase I

                            Sponsor : Abdi Ibrahim

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Pharmaceutical Research Unit, Jordan

                            Country arrow
                            Aquaexpo
                            Not Confirmed

                            Pharmaceutical Research Unit, Jordan

                            Country arrow
                            Aquaexpo
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Dirithromycin

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase I

                            Sponsor : Abdi Ibrahim

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Bioequivalence Pilot Study of Dirithromycin of (Abdi İbrahim İlaç San.Ve.Tic.A.Ş,Turkey) in Health...

                            Details : Dirithromycin is a Antibiotic drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Antibiotic

                            Upfront Cash : Inapplicable

                            July 10, 2014

                            Lead Product(s) : Dirithromycin

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase I

                            Sponsor : Abdi Ibrahim

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth